EUPRAXIA PHARMACEUTICALS INC. (EPRX) Net income 2022–2025
EUPRAXIA PHARMACEUTICALS INC. (EPRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$38.6MFY2025 · since FY2022: -$18.5M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.6M | -51.3% |
| FY2024 | -$25.5M | +9.6% |
| FY2023 | -$28.2M | -52.6% |
| FY2022 | -$18.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EPRX financial trends
EPRX RevenueEPRX Net marginEPRX Gross profitEPRX Gross marginEPRX Operating incomeEPRX Operating marginEPRX Operating cash flowEPRX Free cash flowEPRX Capital expendituresEPRX Return on equityEPRX Stock buybacksEPRX Dividends paidEPRX Total assetsEPRX Total liabilitiesEPRX Shareholders’ equityEPRX overview →